CoChat

Impact of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the Educ@dom Randomised Multicentre Study

Open access

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Telemonitoring in type 2 diabetes (T2D) is mainly based on glucose monitoring. A new type of connected device which routinely gathers data on weight, physical activity and food intake could improve patients’ diabetes control. The main aim of this study was to assess the efficacy of an at-home interventional programme incorporating such devices and lifestyle education software on diabetes control, i.e., change in HbA1c, compared to standard care. This multicentre study randomly assigned 282 people with T2D to either a telemonitoring group (TMG) or a control group (CG) for a 1-year intervention period. While routine follow-up was maintained in the CG, TMG subjects were provided with interactive lifestyle educational software (with artificial intelligence algorithms) and connected objects (blood glucose meters, scales and actimeters) for use in their own homes and were remotely monitored by their diabetologists. Changes in HbA 1c were compared between groups using a mixed linear model. The mean HbA 1c dropped from 7.8 ± 0.8% (62 mmol/mol) to 7.4 ± 1.0% (57 mmol/mol) in the TMG and from 7.8 ± 0.8% (62 mmol/mol) to 7.6 ± 1.0% (60 mmol/mol) in the CG, resulting in an intergroup difference of − 0.16 ( p = 0.06) in favour of TMG, after adjustment for confounding factors. Within TMG, the decrease in HbA 1c was greater in frequent users: − 0.23% ( p = 0.03) in the case of connections to telemonitoring synthesis above the median and − 0.21% ( p = 0.05) in the case of connections to tele-education software above the median compared to the CG. Significant weight loss was observed in the TMG but only in women ( p = 0.01). The EDUC@DOM telemonitoring and tele-education device did not highlight a significant decrease in HbA1c levels compared to routine management although a slight, albeit significant improvement in glycaemic control was observed in the frequent user subgroup as well as significant weight loss but only in women. A high level of satisfaction with the connected device was recorded amongst all participants. This trial was registered in the Clinical Trials Database on September 27, 2013, under no. NCT01955031 and bears ID-RCB number 2013-A00391-44.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s13300-021-01095-x

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Flow chart
Fig. 1 Flow chartCC BY-NC · PubMed Central
Fig. 2 Mean HbA1c observed (at baseline) or predicted according to time of follow-up
Fig. 2 Mean HbA1c observed (at baseline) or predicted according to time of follow-upCC BY-NC · PubMed Central
Fig. 3 Correlations between frequency of use and changes in HbA1c and BMI. With: solid lines for non-parametric (Lowess) models and dashed lines for linear models. Since the correlations are graphically linear, the following are presented: ρ, Pearson correlation coefficient, with confidence intervals estimated by bootstrapping (1000 replications) and p value by the Pearson correlation coefficient test.
Fig. 3 Correlations between frequency of use and changes in HbA1c and BMI. With: solid lines for non-parametric (Lowess) models and dashed lines for linear models. Since the correlations are graphically linear, the following are presented: ρ, Pearson correlation coefficient, with confidence intervals estimated by bootstrapping (1000 replications) and p value by the Pearson correlation coefficient test.CC BY-NC · PubMed Central
Fig. 4 Evaluation of device use by telemonitored patients
Fig. 4 Evaluation of device use by telemonitored patientsCC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 22

Metadata

Authors
Turnin, M.-C., Gourdy, P., Martini, J., Buisson, J.-C., Chauchard, M.-C., Delaunay, J., Schirr-Bonnans, S., Taoui, S., Poncet, M.-F., Cosma, V., Lablanche, S., Coustols-Valat, M., Chaillous, L., Thivolet, C., Sanz, C., Penfornis, A., Lepage, B., Colineaux, H., Mounié, M., Costa, N., Molinier, L., Hanaire, H., & the Educ@dom Study Group
Affiliations
  • Centre Hospitalier Universitaire de Toulouse (FR)
  • Université Toulouse III - Paul Sabatier (FR)
  • École Nationale Supérieure d'Électrotechnique, d'Électronique, d'Informatique, d'Hydraulique et des Télécommunications (FR)
  • Clinique Claude-Bernard (FR)
  • Centre Hospitalier Universitaire de Grenoble (FR)
  • Centre Hospitalier Universitaire de Nantes (FR)
  • Clinique Pasteur (FR)
  • Université Paris-Saclay (FR)
Corresponding author
  • Turnin, Marie-Christine
  • Chauchard, Marie-Christine
Venue
Diabetes Therapy
Published
2021-06-23
Volume
12
Issue
7
Pages
2059-2075
ISSN
  • 1869-6953 (ISSN-L)
  • 1869-6961
OpenAlex
W3174503584
Cited by
20
References
43
Citations by year
2026: 6 · 2025: 5 · 2024: 4 · 2023: 4 · 2022: 1
FWCI
2.53
Type
journal article
Language
en
Open access
Licence
Locations
  • Diabetes Therapy (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by-nc)
Funders
  • Ministère des Affaires Sociales, de la Santé et des Droits des Femmes (12-018-0078)
  • Conseil Régional Midi-Pyrénées (11052617, 13050630)
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
Keywords
type 2 diabetes, remote patient monitoring, artificial intelligence, IoT devices, blood glucose meters, HbA1c, glycemic control, weight loss, user engagement, patient satisfaction, home-based intervention, sex differences, digital health interventions, physical activity monitoring, dietary monitoring

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.